July 20, 2024

Muscle Stimulator Market Size Analysis 2022 To 2030

The global muscle stimulator market size accounted for US$ 695 million in 2021 and is projected to reach around USD 941 million by 2030, growing at a CAGR of 3.42% from 2022 to 2030. The rising predominance of outer muscle problems among residents, the developing ubiquity of the muscle stimulators among the physiotherapists, and the expansion in the medical care financial plans are driving the growth of the muscle stimulator market

Muscle Stimulator Market Key Takeaways:

  • By modality, the portable and handheld segment hit highest market share of over 79% in 2021.
  • By application, the pain management segment has generated 55% market share in 2021.
  • By end user, physiotherapy facilities segment held 41% market share in 2021.
  • The North America region has accounted 47% of the total revenue share in 2021.

Muscle Stimulator Market Size 2022 To 2030

Muscle stimulators are a variety of devices that work on the principle of using electrical impulses on muscles as a way of relieving chronic pain. Techniques such as transcutaneous electrical nerve stimulation, interferential stimulation, neuromuscular electric stimulation, and burst mode alternating current are commonly utilized in muscle stimulators. Muscle stimulators are also used for improving muscle strength, muscle control, blood circulation, and toning muscles.

A variety of muscle stimulators are available in the global market and new varieties continue to flow into the global market as companies plough increased resources into R&D practices to stay ahead of competition. As technologies advance, awareness regarding to health rises, understanding regarding sports medicine becomes more profound, and healthcare budgets expand, the market for muscle stimulators is also expected to expand.

Report Summary

The global muscle stimulator market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the muscle stimulator market across the globe.

A comprehensive estimate on the muscle stimulator market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of muscle stimulator during the forecast period. Price point comparison by region with global average price is also considered in the study.

Muscle Stimulator Market Scope

Report CoverageDetails
Market Size in 2022USD 718.8 million
Market Size by 2030USD 941 million
Growth Rate from 2022 to 2030CAGR of 3.42%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredProduct Type, Modality, Application, End-user, and Geography

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized muscle stimulator market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Muscle Stimulator Market Potential

Muscle stimulators are commonly used for treating chronic pain in the back and legs. In the past few years, the number of people suffering from chronic pain has considerably increased. The attempts made by healthcare agencies in recognizing chronic pain as a major healthcare concern has led to an increased awareness among the global population about the need to adhere to effective courses of treatment for their chronic pain conditions. Muscle stimulators are also used by athletes for relieving pain triggered by intense practice sessions and strenuous tournaments. The rising numbers of participants in several sports activities worldwide could also propel the global muscle stimulation devices market.

Also Read: Extended Warranty Market Size Analysis 2022 To 2030

COVID-19 Impact:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Muscle Stimulator Market Players

The report includes the profiles of key muscle stimulator market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area are:

  • AxioBionics
  • Beurer GmbH
  • BioMedical Life Systems
  • Colfax Corporation
  • EMS Physio Ltd.
  • Liberate Medical
  • OG Wellness Technologies Co., Ltd.
  • RS Medical
  • Zimmer MedizinSysteme GmbH
  • Zynex Medical

Market Segmentation

By Product Type

  • Neuromuscular Electrical Stimulation
  • Functional Electrical Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Interferential
  • Burst Mode Alternating Current
  • Micro Current Electrical Neuromuscular Stimulator
  • Others

By Modality 

  • Handheld
  • Portable
  • Table Top

By Application 

  • Pain Management
  • Neurological Disorder
  • Musculoskeletal Disorder
    • Muscle Rehabilitation
    • Muscle Atrophy
    • Muscle Toning & Strengthening
    • Muscle Spasticity & Spasms
  • Others

By End-user 

  • Hospitals
  • Ambulatory Surgical Centers
  • Physiotherapy Clinics
  • Sports Clinics
  • Home Care

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Muscle Stimulator Market 

5.1. COVID-19 Landscape: Muscle Stimulator Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Muscle Stimulator Market, By Product Type

8.1. Muscle Stimulator Market, by Product Type, 2022-2030

8.1.1. Neuromuscular Electrical Stimulation

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Functional Electrical Stimulation

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Transcutaneous Electrical Nerve Stimulation

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Interferential

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Burst Mode Alternating Current

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Micro Current Electrical Neuromuscular Stimulator

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Muscle Stimulator Market, By Modality

9.1. Muscle Stimulator Market, by Modality, 2022-2030

9.1.1. Handheld

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Portable

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Table Top

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Muscle Stimulator Market, By Application 

10.1. Muscle Stimulator Market, by Application, 2022-2030

10.1.1. Pain Management

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Neurological Disorder

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Musculoskeletal Disorder

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Muscle Stimulator Market, By End-user 

11.1. Muscle Stimulator Market, by End-user, 2022-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Ambulatory Surgical Centers

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Physiotherapy Clinics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Sports Clinics

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Home Care

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Muscle Stimulator Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Modality (2017-2030)

12.1.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.4. Market Revenue and Forecast, by End-user (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Modality (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Modality (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Modality (2017-2030)

12.2.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Modality (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Modality (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Modality (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Modality (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Modality (2017-2030)

12.3.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Modality (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Modality (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Modality (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Modality (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Modality (2017-2030)

12.4.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Modality (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Modality (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Modality (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Modality (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Modality (2017-2030)

12.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Modality (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Modality (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-user (2017-2030)

Chapter 13. Company Profiles

13.1. AxioBionics

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Beurer GmbH

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. BioMedical Life Systems

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Colfax Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. EMS Physio Ltd.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Liberate Medical

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. OG Wellness Technologies Co., Ltd.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. RS Medical

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Zimmer MedizinSysteme GmbH

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Zynex Medical

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2192

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →